Research Achievements: Published over 30 papers in domestic and international journals including Oncogene, JAMA Network Open, Cancer, Nano Letters, Angew Chem Int Ed, etc. Applied for and was granted 1 patent. Participated in the compilation of multiple oncology professional books and domestic authoritative treatment guidelines, including "Gastric Cancer: Translational Research from Bench to Bedside," "Tumor Biotherapy," "Melanoma: Basic and Clinical," "Rehabilitation Guide for Cancer Patients," "CSCO Guidelines for the Diagnosis and Treatment of Cancer Cachexia" (2021 edition), "Chinese Expert Consensus on the Prevention and Treatment of Nausea and Vomiting Associated with Antineoplastic Drugs" (2022 edition), and "Chinese Expert Consensus on the Diagnosis and Treatment of Antineoplastic Drug-Related Thrombocytopenia" (2023 edition). Research Direction: Long-term engagement in research on the mechanisms of cell fate determination and immune microenvironment regulation in gastrointestinal tumors, aiming to achieve precision therapy for tumors by improving the tumor microenvironment and screening novel biomarkers. Presided over a total of 9 research projects at various levels, including 3 projects funded by the National Natural Science Foundation of China. Individual Honors: Successively selected for the "Research Physician Innovation and Translation Capacity Training" Program of Shanghai Shenkang Hospital Development Center, the "Menmei Zhiguang · Huangpu Young Talent" Program, the "Double Hundred Talents" Program of Shanghai Jiao Tong University, and the "Young Physician Scientist Top-notch Cultivation" Program of Shanghai Institute of Immunotherapy Innovation.